학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 16건 | 목록
1~20
Academic Journal
Fridén-Saxin M; Seifert T; Malo M; da Silva Andersson K; Pemberton N; Dyrager C; Friberg A; Dahlén K; Wallén EA; Grøtli M; Luthman K
European Journal of Medicinal Chemistry. 114:59-64
Academic Journal
Fridén-Saxin, Maria, 1979; Seifert, Tina, 1985; Landergren, M. R.; Suuronen, T.; Lahtela-Kakkonen, M.; Jarho, E. M.; Luthman, Kristina, 1953
Journal of Medicinal Chemistry. 55(16):7104-7113
Academic Journal
Nordqvist A; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; O'Mahony G; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Fridén-Saxin M; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Fredenwall M; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Hogner A; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Granberg KL; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Aagaard A; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Bäckström S; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Gunnarsson A; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Kaminski T; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Xue Y; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Dellsén A; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Hansson E; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Hansson P; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Ivarsson I; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Karlsson U; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.; Bamberg K; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Hermansson M; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Georgsson J; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Lindmark B; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 43183, Sweden.; Edman K; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE
Academic Journal
Kennedy AJ; Mechanistic Biology & Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; MSD at the Francis Crick Institute, London, UK.; Sundström L; Mechanistic Biology & Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Geschwindner S; Structure & Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Poon EKY; Centre for Inflammation and Disease Research (CIDR) and ARC Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia.; Jiang Y; Centre for Inflammation and Disease Research (CIDR) and ARC Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia.; Chen R; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, 100176, Beijing, People's Republic of China.; Cooke R; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG, UK.; Johnstone S; Department of Chemistry, IntelliSyn Pharma, 7171 Frederick-Banting, Montreal, QC, H4S 1Z9, Canada.; Madin A; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.; Lim J; Centre for Inflammation and Disease Research (CIDR) and ARC Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia.; Liu Q; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, 100176, Beijing, People's Republic of China.; Lohman RJ; Centre for Inflammation and Disease Research (CIDR) and ARC Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia.; Nordqvist A; Medicinal Chemistry, Cardiovascular, Renal & Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Fridén-Saxin M; Alliance & Project Management, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Yang W; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, 100176, Beijing, People's Republic of China.; Brown DG; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Boston, MA, USA.; Fairlie DP; Centre for Inflammation and Disease Research (CIDR) and ARC Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, 4072, Australia.; Dekker N; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. niek.dekker@astrazeneca.com.
Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
Academic Journal
Seifert, Tina; Malo, Marcus; Kokkola, Tarja; Engen, Karin; Friden-Saxin, Maria; Wallen, Erik A. A.; Lahtela-Kakkonen, Maija; Jarho, Elina M.; Luthman, Kristina
Academic Journal
Leitch EK; Chemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.; Elumalai N; Chemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.; Fridén-Saxin M; Medicinal Chemistry , Cardiovascular and Metabolic Diseases , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.; Dahl G; Structure and Biophysics , Discovery Sciences , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.; Wan P; Structure and Biophysics , Discovery Sciences , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.; Clarkson P; AstraZeneca , Cambridge Science Park, 310 Milton Rd , Cambridge , CB4 0FZ , UK.; Valeur E; Medicinal Chemistry , Cardiovascular and Metabolic Diseases , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.; Pairaudeau G; AstraZeneca , Cambridge Science Park, 310 Milton Rd , Cambridge , CB4 0FZ , UK.; Boyd H; Drug Safety and Metabolism , IMED Biotech Unit , AstraZeneca , Pepparedsleden 1 , Mölndal , 43150 , Sweden.; Tavassoli A; Chemistry , University of Southampton , Southampton , SO17 1RE , UK . Email: a.tavassoli@soton.ac.uk.; Institute for Life Sciences , University of Southampton , Southampton , SO17 1BJ , UK.
Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101545951 Publication Model: eCollection Cited Medium: Print ISSN: 2041-6520 (Print) Linking ISSN: 20416520 NLM ISO Abbreviation: Chem Sci Subsets: PubMed not MEDLINE
Academic Journal
In: Synthesis (Germany) . (Synthesis (Germany), 3 April 2018, 50(7):1471-1481)
Academic Journal
Seifert, Tina; Malo, Marcus; Kokkola, Tarja; Engen, Karin; Fridén-Saxin, Maria; Wallén, Erik A. A.; Lahtela-Kakkonen, Maija; Jarho, Elina M.; Luthman, Kristina
Academic Journal
In: Organic Process Research and Development . (Organic Process Research and Development, 16 March 2018, 22(3):337-343)
Academic Journal
Fridén-Saxin, Maria; Seifert, Tina; Landergren, Marie Rydén; Suuronen, Tiina; Lahtela-Kakkonen, Maija; Jarho, Elina M.; Luthman, Kristina
Academic Journal
Dyrager C; Department of Chemistry, Medicinal Chemistry, University of Gothenburg, Göteborg, Sweden.; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE
Academic Journal
Ankner T; Department of Chemistry, University of Gothenburg, Göteborg, Sweden.; Fridén-Saxin M; Pemberton N; Seifert T; Grøtli M; Luthman K; Hilmersson G
Publisher: American Chemical Society Country of Publication: United States NLM ID: 100890393 Publication Model: Print Cited Medium: Internet ISSN: 1523-7052 (Electronic) Linking ISSN: 15237052 NLM ISO Abbreviation: Org Lett Subsets: PubMed not MEDLINE
Academic Journal
Dyrager C; Department of Chemistry-Medicinal Chemistry, University of Gothenburg, 412 96 Göteborg, Sweden.; Friberg A; Dahlén K; Fridén-Saxin M; Börjesson K; Wilhelmsson LM; Smedh M; Grøtli M; Luthman K
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9513783 Publication Model: Print Cited Medium: Internet ISSN: 1521-3765 (Electronic) Linking ISSN: 09476539 NLM ISO Abbreviation: Chemistry Subsets: MEDLINE
Academic Journal
Fridén-Saxin M; Department of Chemistry, Medicinal Chemistry, University of Gothenburg, SE-41296 Goteborg, Sweden.; Pemberton N; Andersson Kda S; Dyrager C; Friberg A; Grøtli M; Luthman K
Publisher: American Chemical Society Country of Publication: United States NLM ID: 2985193R Publication Model: Print Cited Medium: Internet ISSN: 1520-6904 (Electronic) Linking ISSN: 00223263 NLM ISO Abbreviation: J Org Chem Subsets: MEDLINE
Academic Journal
In: Tetrahedron . (Tetrahedron, 2 September 2012, 68(35):7035-7040)
Academic Journal
검색 결과 제한하기
제한된 항목
[검색어] Fridén-Saxin, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어